Примери за използване на Initial opinion на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
This changed my initial opinion.
An initial opinion or referral to a specialist organisation.
I am wrong with my initial opinion.
Does your initial opinion of people or situations too quickly become a judgment about them and expectation of them?
Be ready to change your initial opinion.
In its initial Opinion, the CHMP did not conclude that the formulations analysed were unaffected by alcohol.
It had issued its initial opinion on 27 June 2019.
The company requested a re-examination of the initial opinion.
When looking at the whole product, the initial opinion of the color or shade may change.
The company requested a re-examination of the initial opinion.
After re-examination, the CHMP confirmed its initial opinion that the marketing authorisation could not be granted.
The MAHs did not submit the above mentioned scientific data before the adoption of the initial opinion.
After having considered the grounds for this request, the CHMP re-examined the initial opinion, and confirmed the refusal of the marketing authorisation on 24 January 2008.
The MAH did not exercise the right to submit the above mentioned scientific data for assessment before the adoption of the initial opinion.
The design of your internet side build up the initial opinion of the users for you.
If there is a request for re-examination of one of its opinions, the Committee concerned shall appoint a different rapporteur and, where necessary,a different co-rapporteur from those appointed for the initial opinion.
After considering the grounds for this request, the CHMP re examined the initial opinion, and confirmed the refusal of the change to the marketing authorisations on 17 November 2011.
If there is a request for re-examination of one of its opinions, the Committee concerned shall appoint a different rapporteur and, where necessary,a different co-rapporteur from those appointed for the initial opinion.
After considering the grounds for this request, the CHMP re-examined the initial opinion, and confirmed the refusal of the marketing authorisation on 20 March 2014.
If there is a request for re-examination of one of its opinions where this possibility is provided for in Union law, the Committee concerned shall appoint a different rapporteur and, where necessary,a different co-rapporteur from those appointed for the initial opinion.
After considering the grounds for this request, the CHMP re-examined the initial opinion and confirmed the refusal of the marketing authorisation on 1 April 2016.
As stated in Article 62(1) paragraph 4 of Regulation(EC) No 726/2004 and Article 32(4) paragraph 3 of Directive 2001/83/EC,“the re-examination procedure may deal only with the points of the opinion initially identified by the applicant/MAH andmay be based only on the scientific data available when the Committee adopted the initial opinion.” Therefore these scientific data can not be considered during the re-examination procedure.
After considering the grounds for this request, the CHMP re-examined the initial opinion, and confirmed the refusal of the marketing authorisation on 17 November 2011.
Following further communication with the European Commission in years 2007 and 2008 on the opinion and the scope of the procedure, the CVMP in the July 2008 plenary meeting agreed to complete the procedure under Article 78 of Directive 2001/82/EC, as amended,for all marketing authorisations held in the EU for the 21 products containing alpha2-adrenoreceptor agonists initially notified and to revise the initial opinion accordingly.
After having considered the grounds for this request, the CHMP re-examined the initial opinion, and confirmed the refusal of the marketing authorisation on 20 November 2008.
Resume is of great importance,because it is for the employer it will make its initial opinion about you as a job seeker.
Based on the arguments of the applicant and all the supporting data on safety and efficacy,the CHMP re-examined its initial opinion and in its final opinion concluded by majority decision that the efficacy of the above mentioned medicinal product is not sufficiently demonstrated, and, therefore maintains its recommendation for the refusal of the variation of the Marketing Authorisation for the above mentioned medicinal product.
After considering the grounds for this request, the CHMP re-examined the initial opinion, and confirmed the refusal of the marketing authorisation on 25 July 2013.
After considering the grounds for this request,the CHMP re-examined the initial opinion and confirmed the refusal of the marketing authorisation on 22 October 2015.
After considering the grounds for this request,the CVMP re-examined the initial opinion, and confirmed the refusal of the marketing authorisation on 7 May 2015.